Subcutaneous patient-controlled analgesia with hydromorphone for the treatment of refractory cancer pain in older hospitalized patients: a retrospective real-world study - Poll - MDSpire

Subcutaneous patient-controlled analgesia with hydromorphone for the treatment of refractory cancer pain in older hospitalized patients: a retrospective real-world study

  • By

  • Hong Yang

  • Yiming Shen

  • Mengting Chen

  • Junhui Zhang

  • Lei Lei

  • Huiqing Yu

  • June 9, 2026

  • 0 min

Share

Original Source(s)

Subcutaneous patient-controlled analgesia with hydromorphone for the treatment of refractory cancer pain in older hospitalized patients: a retrospective real-world study

  • by Hong Yang, Yiming Shen, Mengting Chen, Junhui Zhang, Lei Lei, Huiqing Yu

  • June 9, 2026

Related Content

TIFA: a signaling hub linking inflammation, innate immunity, and human disease

The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics

Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression